S100P and neoplasm: Strikingly, within the group of patients bearing E-cadherin negative tumours, those expressing S100P had the worst prognosis of the cohort, substantiating our cellular studies and supporting its oncogenic role as previously suggested for a number of cancers, including GC [12].